AN

Avinash Nivritti Supe

Director DIN 08328787
DIN 08328787 First appointment Nov 2010
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 2 historical roles
Total affiliations 2 Since Nov 2010
Shareholding value β€’β€’β€’β€’ Premium profile

About Avinash Nivritti Supe

Data last updated:

Avinash Nivritti Supe was a Director at Hinduja Healthcare Limited (from 2019) and Partner at Indian Collaborative Clinical Research O Rganisation Llp (from 2010).

DIN 08328787
First Appointment 24 Nov 2010
Oldest Company Age 27 yrs

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Hinduja Healthcare Limited U02002MH1998PLC117080
Director18 Jan 20191998₹73.02 Cr (FY 2024)Amalgamated
Partner24 Nov 20102010Strike Off

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Hinduja Healthcare Limited
Indian Collaborative Clinical Research O Rganisation Llp
Premium access

Shareholding and investment profile for Avinash Nivritti Supe

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Avinash Nivritti Supe

Avinash Nivritti Supe was first appointed on 24 Nov 2010 as Partner at Indian Collaborative Clinical Research O Rganisation Llp. The most recent appointment on record is 18 Jan 2019 at Hinduja Healthcare Limited.

Avinash Nivritti Supe held 2 earlier board appointments: Hinduja Healthcare Limited (Director, from 18 Jan 2019); Indian Collaborative Clinical Research O Rganisation Llp (Partner, from 24 Nov 2010).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available